论文部分内容阅读
目的:探讨氨氯地平阿托伐他汀钙片治疗原发性高血压并高血脂症的临床疗效。方法:本次研究的94例原发性高血压并高血脂症患者均为本院在2014年6月-2015年8月收治,参照随机数字法将其分为观察组48例和对照组46例,观察组应用氨氯地平阿托伐他汀钙片治疗,对照组患者采取阿托伐他汀钙片治疗,对比两组患者的治疗效果及血脂、血压变化。结果:观察组治疗总有效率为93.8%,明显高于对照组的80.4%(P<0.05);经治疗,观察组患者血压和血脂水平均低于对照组(P<0.05)。结论:原发性高血压并高血脂症患者应用氨氯地平阿托伐他汀钙片治疗的临床疗效肯定,其在降低患者血压、血脂方面有积极作用。
Objective: To investigate the clinical efficacy of amlodipine atorvastatin calcium in the treatment of essential hypertension and hyperlipidemia. Methods: The 94 patients with essential hypertension and hyperlipidemia in our study were all admitted to our hospital from June 2014 to August 2015. According to the random number method, they were divided into observation group (48 cases) and control group In the observation group, amlodipine atorvastatin calcium tablets were used in the observation group. Atorvastatin calcium tablets in the control group were compared with those in the two groups, and the changes of blood lipids and blood pressure were compared. Results: The total effective rate in the observation group was 93.8%, which was significantly higher than that in the control group (80.4%, P <0.05). After treatment, the blood pressure and blood lipids in the observation group were lower than those in the control group (P <0.05). Conclusion: The clinical efficacy of amlodipine atorvastatin calcium tablets in patients with essential hypertension and hyperlipidemia is positive, which has a positive effect on reducing blood pressure and blood lipid in patients.